| Problem
List |
: |
TYPE 2 DM (23/Jun/2018) | HYPERTENSION (26/Jun/2018) | DISTAL SENSORY NEUROPATHY (29/Sep/2011) | NAFLD (27/May/2022) | |
|
Subjective |
: |
NO NEW COMPLAINTS,HAS VERTIGO,LOST TO FOLLOW UP |
|
Objective |
: |
NONE |
|
Analysis |
: |
HYPERTENSION,NAFLD WITH INCREASED RISK OF PROGESSION,TYPE 2 DM WORSENED CONTROL |
|
Plan |
: |
INCREASE TZD TO 15 MG,SEE ME IN 2 MONTHS WITH TESTING |
|
| Salient Investigations |
: |
BUN BLOOD UREA NITROGEN: 12.1 mg/dL | FASTING PLASMA GLUCOSE (FPG): 149 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 8.4 % | POST PRANDIAL GLUCOSE (2HPP): 243 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 37 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 76.6 mg/dL | TGL TRIGLYCERIDE: 162 mg/dL | TOTAL CHOLESTEROL: 146 mg/dl | ALBUMIN (SERUM): 4.3 g/dL | ALKALINE PHOSPHOTASE: 105 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 18 U/L | SGPT (ALT): 14 IU/L | TOTAL BILIRUBIN: 0.3 mg/dL | CREATININE: 1 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 78.43 mL/min/1.73m2 | UREA: 25.8 mg/dL | URIC ACID: 5.9 | BICARBONATE: 22 meq/L | CHLORIDE: 98 meq/L | POTASSIUM: 4.7 meQ/L | SODIUM: 135 meq/L | HEMOGLOBIN: 12.9 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 85.5 fL | PLATELETS: 411 thou cells/ ul | FIB4: 0.83 | WBC WHITE BLOOD CELLS: 917 K/uL |
